New Delhi, October 5, 2026 — DDReg Pharma has been named the Official Winner in the Entrepreneur of the Year in Service Business – Healthcare category at the 16th Edition of the Entrepreneur India Awards 2026, held at Bharat Mandapam, New Delhi.
The recognition marks an important milestone in DDReg Pharma’s journey as a life sciences consulting company supporting pharmaceutical, biotechnology, and medical device organisations with specialised regulatory expertise. It reflects the growing importance of professional services that help businesses navigate complex regulatory requirements, manage product lifecycle responsibilities, and address compliance obligations across global markets.
Recognising Excellence at Entrepreneur India Awards 2026
The Entrepreneur India Awards recognise business achievements and innovation across industries, bringing together entrepreneurs, business leaders, investors, and innovators to celebrate contributions to India’s evolving business landscape.
The 16th edition of the awards featured more than 1500+ attendees, 150+ speakers, 75+ award categories, 250+ startups, and 6 summits focused on business and innovation.
For DDReg Pharma, being named the official winner in the Entrepreneur of the Year in Service Business category represents a significant achievement and an opportunity to recognise the role of specialised consulting in the life sciences industry.
Advancing Regulatory Expertise Across the Life Sciences Industry
Bringing pharmaceutical products and medical devices to market requires more than preparing regulatory submissions. Organisations must interpret country-specific regulations, maintain compliant documentation, respond to evolving requirements, and fulfil ongoing product safety obligations throughout the product lifecycle.
These responsibilities become increasingly complex when companies operate across multiple markets, each with its own regulatory framework, submission requirements, and post-approval obligations.
DDReg Pharma supports pharmaceutical, biotechnology, and medical device organisations through specialised consulting services designed to address these challenges.
Its key service areas include:
- Regulatory Affairs Services: Supporting organisations in navigating regulatory requirements, submissions, and product lifecycle activities across markets.
- Pharmacovigilance Services: Supporting drug safety activities and pharmacovigilance obligations throughout the product lifecycle.
- Clinical Regulatory Services: Supporting regulatory requirements associated with clinical research and clinical development activities.
By bringing together regulatory knowledge and specialised service capabilities, DDReg Pharma works to help organisations approach regulatory responsibilities with greater clarity and structure.
Building on this Achievement
The Entrepreneur India Awards 2026 recognition marks an important chapter in DDReg Pharma’s development. It also reinforces the relevance of specialised regulatory consulting in an industry where compliance, product quality, and patient safety remain essential considerations.
As regulatory frameworks and market expectations continue to evolve, DDReg Pharma remains focused on strengthening its expertise and supporting life sciences organisations in addressing regulatory requirements across global markets.
The company views this milestone as an opportunity to build on its progress while continuing to support clients with regulatory affairs, pharmacovigilance, clinical regulatory, and related consulting services.
About DDReg Pharma
DDReg Pharma is a life sciences consulting company providing regulatory affairs, pharmacovigilance, clinical research, and related services to pharmaceutical, biotechnology, and medical device organisations. The company supports clients in navigating regulatory requirements, managing product lifecycle responsibilities, and progressing through complex regulatory processes across markets.